This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Inflation at its current levels poses a major threat to generics production and usage. Since the summer, generics makers have been signalling that additional support for help with rising costs is required to keep generics production viable. Inflation can damage production viability of European drugs.
Earlier this year, Sun Pharmaceutical Industries , one of India’s largest genericdrug producers, reported a major cybersecurity breach , impacting its business operations. Pharmacompanies around the world have also faced similar threats , some of which have impacted national security and public health.
In November 2017, Foundation Medicine received approval for FoundationOne CDx , a genomic profiling test for solid state tumors, which paved the way for partnerships with pharmacompanies’ therapeutics. The genericdrug must also have the same labeling as the RLD (except for differences permitted under the Agency regulations).
Logistical challenges of getting the right materials in the right place remain two years after the pandemic began, causing significant drug shortages to end-users. Many of the medicines most badly affected by these shortages are genericdrugs to treat common conditions such as diabetes and heart disease. The stakes are high.
Without precise targeting, ad spend can be wasted on irrelevant searches, reducing conversion rates and compliance effectiveness. Unlike consumer brands that can use aggressive bidding strategies on high-volume keywords, pharma ads must navigate strict regulatory guidelines. But how do you balance compliance with visibility?
Unlike traditional marketing, digital marketing allows brands to engage with HCPs and patients in real time while maintaining compliance with industry regulations. Drive prescription intent by educating HCPs about the latest drug advancements. Ensure compliance while leveraging digital tools for outreach.
Let’s explore the top strategies pharma marketers can adopt to thrive. Understanding the Pharma Market Landscape To succeed, you need to understand the shifting dynamics of healthcare marketing. Use relatable metaphors: Think of content as a bridge connecting pharmacompanies with patients and HCPs.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content